Treatment With Baricitinib for Patients With COVID-19 Infections: A Case-Series Study
C. Ravaglia (Forlì, Italy), S. Piciucchi (Forlì, Italy), S. Oldani (Forlì, Italy), L. Bertolovic (Forlì, Italy), S. Bensai (Forlì, Italy), C. Colinelli (Forlì, Italy), S. Simoncelli (Forlì, Italy), C. Ghirotti (Forlì, Italy), S. Puglisi (Forlì, Italy), L. Donati (Forlì, Italy), G. Ravaglia (Forlì, Italy), F. Landi (Forlì, Italy), M. Terzitta (Forlì, Italy), V. Poletti (Forlì, Italy)
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Session: Diagnosis and management of COVID-19
Session type: E-poster
Number: 454
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Ravaglia (Forlì, Italy), S. Piciucchi (Forlì, Italy), S. Oldani (Forlì, Italy), L. Bertolovic (Forlì, Italy), S. Bensai (Forlì, Italy), C. Colinelli (Forlì, Italy), S. Simoncelli (Forlì, Italy), C. Ghirotti (Forlì, Italy), S. Puglisi (Forlì, Italy), L. Donati (Forlì, Italy), G. Ravaglia (Forlì, Italy), F. Landi (Forlì, Italy), M. Terzitta (Forlì, Italy), V. Poletti (Forlì, Italy). Treatment With Baricitinib for Patients With COVID-19 Infections: A Case-Series Study. 454
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: